1月28日,全球骨科巨头史赛克(Stryker)宣布会将表现不佳的美国脊柱植入业务出售给一家投资家族,这或是其全面剥离脊柱业务的开始。01全面剥离?史赛克宣布将其美国的脊柱业务出售给一家专注于神经肌肉骨骼领域的家族投资公司Viscogliosi Brothers。同时,史赛克还考虑将法国脊柱业务也打包出售给后者,不过需要与员工代表协商。预计这笔交易将于2025年上半年完成。而Viscogliosi...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.